DD vs SGMO · P/E 127, rev $12.39B vs rev $57.8M
Dupont De Nemours Inc (DD) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the DD and SGMO stock pages for the full models.
Not investment advice.